- Home
- Publications
- Publication Search
- Publication Details
Title
Parkinson’s disease: an update on pathogenesis and treatment
Authors
Keywords
Parkinsons disease, Pathogenesis, Treatment, Update
Journal
JOURNAL OF NEUROLOGY
Volume 260, Issue 5, Pages 1433-1440
Publisher
Springer Nature
Online
2013-04-15
DOI
10.1007/s00415-013-6915-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Urate and the Risk of Parkinson's Disease: Results From a Meta-Analysis
- (2014) Chunhong Shen et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
- (2013) Sophie E. Winder-Rhodes et al. BRAIN
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
- (2013) Jens Volkmann et al. JOURNAL OF NEUROLOGY
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease
- (2012) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
- (2012) Peter Holmans et al. HUMAN MOLECULAR GENETICS
- Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic
- (2012) Daniela M. Arduíno et al. HUMAN MOLECULAR GENETICS
- Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy
- (2012) Y. Lee et al. HUMAN MOLECULAR GENETICS
- The link between the GBA gene and parkinsonism
- (2012) Ellen Sidransky et al. LANCET NEUROLOGY
- Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity
- (2012) Thai Leong Yap et al. MOLECULAR GENETICS AND METABOLISM
- Pathogenesis of Parkinson's disease
- (2012) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies
- (2012) Erwan Bezard et al. MOVEMENT DISORDERS
- Living on the edge with too many mouths to feed: Why dopamine neurons die
- (2012) J. Paul Bolam et al. MOVEMENT DISORDERS
- The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease
- (2012) Raquel Duran et al. MOVEMENT DISORDERS
- Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
- (2012) Joshua A Goldberg et al. NATURE NEUROSCIENCE
- Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
- (2012) Michael W.J. Cleeter et al. NEUROCHEMISTRY INTERNATIONAL
- Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
- (2012) Louise M. Collins et al. NEUROPHARMACOLOGY
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
- (2011) Joo-Ho Shin et al. CELL
- Istradefylline for the treatment of Parkinson's disease
- (2011) Ariane Park et al. EXPERT OPINION ON PHARMACOTHERAPY
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- Pathological roles of α-synuclein in neurological disorders
- (2011) Kostas Vekrellis et al. LANCET NEUROLOGY
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease
- (2011) Klaus Seppi et al. MOVEMENT DISORDERS
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
- (2011) Zhihua Liu et al. NATURE IMMUNOLOGY
- Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
- (2011) Lydia Alvarez-Erviti et al. NEUROBIOLOGY OF DISEASE
- Use of ibuprofen and risk of Parkinson disease
- (2011) X. Gao et al. NEUROLOGY
- Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
- (2011) Laura A. Volpicelli-Daley et al. NEURON
- Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
- (2011) Andrey Yurevich Abramov et al. PLoS One
- A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
- (2011) et al. PLoS Genetics
- SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease
- (2010) Pablo Garcia-Reitböck et al. BRAIN
- Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration
- (2010) David T. Dexter et al. JOURNAL OF NEURAL TRANSMISSION
- Gene therapy: a viable therapeutic strategy for Parkinson’s disease?
- (2010) Alexander L. Berry et al. JOURNAL OF NEUROLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study
- (2010) Tanya Simuni et al. MOVEMENT DISORDERS
- Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo
- (2010) Shankar J. Chinta et al. NEUROSCIENCE LETTERS
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases
- (2009) Latha Devi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Neuroinflammation in Parkinson’s Disease
- (2009) Jae-Kyung Lee et al. Journal of Neuroimmune Pharmacology
- Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five year follow-up
- (2009) H. Gervais-Bernard et al. JOURNAL OF NEUROLOGY
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
- (2009) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease
- (2008) CLINICAL NEUROPHARMACOLOGY
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
- (2008) Jia-Yi Li et al. NATURE MEDICINE
- Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases
- (2008) Peter J. Adhihetty et al. NEUROMOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now